ID   TRPV2_RAT               Reviewed;         761 AA.
AC   Q9WUD2; Q5FWT3; Q9JMI8; Q9QYH8;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 2;
DE            Short=TrpV2;
DE   AltName: Full=Osm-9-like TRP channel 2;
DE            Short=OTRPC2;
DE   AltName: Full=Stretch-activated channel 2B;
DE   AltName: Full=Vanilloid receptor-like protein 1;
DE            Short=VRL-1;
GN   Name=Trpv2; Synonyms=Sac2b, Vrl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND TRANSPORTER
RP   ACTIVITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10201375; DOI=10.1038/18906;
RA   Caterina M.J., Rosen T.A., Tominaga M., Brake A.J., Julius D.;
RT   "A capsaicin-receptor homologue with a high threshold for noxious heat.";
RL   Nature 398:436-441(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Ishibashi K.;
RT   "Molecular cloning of a stretch activated channel from rat kidney.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Suzuki M.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RX   PubMed=14622291; DOI=10.1046/j.1432-1033.2003.03811.x;
RA   Jahnel R., Bender O., Munter L.M., Dreger M., Gillen C., Hucho F.;
RT   "Dual expression of mouse and rat VRL-1 in the dorsal root ganglion derived
RT   cell line F-11 and biochemical analysis of VRL-1 after heterologous
RT   expression.";
RL   Eur. J. Biochem. 270:4264-4271(2003).
RN   [6]
RP   INTERACTION WITH SLC50A1, AND SUBCELLULAR LOCATION.
RX   PubMed=14991772; DOI=10.1002/jcb.10775;
RA   Barnhill J.C., Stokes A.J., Koblan-Huberson M., Shimoda L.M., Muraguchi A.,
RA   Adra C.N., Turner H.;
RT   "RGA protein associates with a TRPV ion channel during biosynthesis and
RT   trafficking.";
RL   J. Cell. Biochem. 91:808-820(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, SUBUNIT,
RP   PHOSPHORYLATION, INTERACTION WITH PRKAR2 AND ACBD3, AND TRANSPORTER
RP   ACTIVITY.
RX   PubMed=15249591; DOI=10.1084/jem.20032082;
RA   Stokes A.J., Shimoda L.M., Koblan-Huberson M., Adra C.N., Turner H.;
RT   "A TRPV2-PKA signaling module for transduction of physical stimuli in mast
RT   cells.";
RL   J. Exp. Med. 200:137-147(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-82 AND SER-760, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 75-321, AND ANK REPEATS.
RX   PubMed=16809337; DOI=10.1074/jbc.c600153200;
RA   Jin X., Touhey J., Gaudet R.;
RT   "Structure of the N-terminal ankyrin repeat domain of the TRPV2 ion
RT   channel.";
RL   J. Biol. Chem. 281:25006-25010(2006).
CC   -!- FUNCTION: Calcium-permeable, non-selective cation channel with an
CC       outward rectification. Seems to be regulated, at least in part, by
CC       growth factors, like IGF1, PDGF and morphogenetic neuropeptide/head
CC       activator. May transduce physical stimuli in mast cells. Activated by
CC       temperatures higher than 52 degrees Celsius; is not activated by
CC       vanilloids and acidic pH (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Y5S1, ECO:0000269|PubMed:10201375,
CC       ECO:0000269|PubMed:15249591}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:10201375,
CC         ECO:0000269|PubMed:15249591};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Mg(2+)(in) = Mg(2+)(out); Xref=Rhea:RHEA:29827,
CC         ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10201375};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10201375};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:10201375};
CC   -!- SUBUNIT: Homotetramer (Probable). Interacts with a cAMP-dependent
CC       protein kinase type II regulatory subunit (PRKAR2A or PRKAR2B) and
CC       ACBD3. Interacts with SLC50A1; the interaction probably occurs
CC       intracellularly and depends on TRPV2 N-glycosylation.
CC       {ECO:0000269|PubMed:14991772, ECO:0000269|PubMed:15249591,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q9WUD2; Q9WUD2: Trpv2; NbExp=3; IntAct=EBI-11689641, EBI-11689641;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14622291,
CC       ECO:0000269|PubMed:14991772, ECO:0000269|PubMed:15249591}; Multi-pass
CC       membrane protein {ECO:0000255}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9WTR1}. Melanosome
CC       {ECO:0000250|UniProtKB:Q9Y5S1}. Note=Translocates from the cytoplasm to
CC       the plasma membrane upon ligand stimulation.
CC       {ECO:0000250|UniProtKB:Q9WTR1}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in dorsal root
CC       ganglia, trigeminal ganglia, spinal cord (Lissauer's tract, dorsal horn
CC       and dorsal columns) (at protein level). {ECO:0000269|PubMed:10201375,
CC       ECO:0000269|PubMed:15249591}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:14622291}.
CC   -!- PTM: Phosphorylated by PKA. {ECO:0000269|PubMed:15249591}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family. TrpV
CC       subfamily. TRPV2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA93435.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF129113; AAD26364.1; -; mRNA.
DR   EMBL; AB029330; BAA88637.1; -; mRNA.
DR   EMBL; AB022332; BAA93435.1; ALT_FRAME; mRNA.
DR   EMBL; BC089215; AAH89215.1; -; mRNA.
DR   RefSeq; NP_001257726.1; NM_001270797.1.
DR   RefSeq; NP_001257727.1; NM_001270798.1.
DR   RefSeq; NP_058903.2; NM_017207.3.
DR   PDB; 2ETA; X-ray; 2.20 A; A/B=75-321.
DR   PDB; 2ETB; X-ray; 1.65 A; A=75-321.
DR   PDB; 2ETC; X-ray; 3.10 A; A/B=62-326.
DR   PDB; 5HI9; EM; 4.40 A; A/B/C/D=1-761.
DR   PDB; 6BO4; EM; 4.00 A; A/B/C/D=72-726.
DR   PDB; 6BO5; EM; 3.60 A; A/B/C/D=72-726.
DR   PDB; 6U84; EM; 3.70 A; A/B/C/D=1-761.
DR   PDB; 6U86; EM; 4.00 A; A/B/C/D=1-761.
DR   PDB; 6U88; EM; 3.20 A; A/B/C/D=1-761.
DR   PDB; 6U8A; EM; 3.40 A; A/B/C/D=1-761.
DR   PDB; 6WKN; EM; 3.46 A; A/B/C/D=1-761.
DR   PDB; 7N0M; EM; 3.50 A; A/B/C/D=1-761.
DR   PDB; 7N0N; EM; 4.15 A; A/B/C/D=1-761.
DR   PDB; 7T37; EM; 3.70 A; A/B/C/D=1-761.
DR   PDB; 7T38; EM; 3.80 A; A/B/C/D=1-761.
DR   PDB; 7ZJD; EM; 2.94 A; A/B/C/D=1-761.
DR   PDB; 7ZJE; EM; 3.12 A; A/B/C/D=1-761.
DR   PDB; 7ZJG; EM; 3.49 A; A/B/C/D=1-761.
DR   PDB; 7ZJH; EM; 3.39 A; A/B/C/D=1-761.
DR   PDB; 7ZJI; EM; 3.40 A; A/B/C/D=1-761.
DR   PDB; 8EKP; EM; 2.75 A; A/B/C/D=1-761.
DR   PDB; 8EKQ; EM; 2.60 A; A/B/C/D=1-761.
DR   PDB; 8EKR; EM; 3.00 A; A/B/C/D=1-761.
DR   PDB; 8EKS; EM; 3.10 A; A/B/C/D=1-761.
DR   PDB; 8FFL; EM; 3.47 A; A/B/C/D=1-761.
DR   PDB; 8FFM; EM; 2.90 A; A/B/C/D=1-761.
DR   PDB; 8SLX; EM; 3.23 A; A/B/C/D=1-761.
DR   PDB; 8SLY; EM; 3.32 A; A/B/C/D=1-761.
DR   PDBsum; 2ETA; -.
DR   PDBsum; 2ETB; -.
DR   PDBsum; 2ETC; -.
DR   PDBsum; 5HI9; -.
DR   PDBsum; 6BO4; -.
DR   PDBsum; 6BO5; -.
DR   PDBsum; 6U84; -.
DR   PDBsum; 6U86; -.
DR   PDBsum; 6U88; -.
DR   PDBsum; 6U8A; -.
DR   PDBsum; 6WKN; -.
DR   PDBsum; 7N0M; -.
DR   PDBsum; 7N0N; -.
DR   PDBsum; 7T37; -.
DR   PDBsum; 7T38; -.
DR   PDBsum; 7ZJD; -.
DR   PDBsum; 7ZJE; -.
DR   PDBsum; 7ZJG; -.
DR   PDBsum; 7ZJH; -.
DR   PDBsum; 7ZJI; -.
DR   PDBsum; 8EKP; -.
DR   PDBsum; 8EKQ; -.
DR   PDBsum; 8EKR; -.
DR   PDBsum; 8EKS; -.
DR   PDBsum; 8FFL; -.
DR   PDBsum; 8FFM; -.
DR   PDBsum; 8SLX; -.
DR   PDBsum; 8SLY; -.
DR   AlphaFoldDB; Q9WUD2; -.
DR   EMDB; EMD-14745; -.
DR   EMDB; EMD-14746; -.
DR   EMDB; EMD-14747; -.
DR   EMDB; EMD-14748; -.
DR   EMDB; EMD-14749; -.
DR   EMDB; EMD-20677; -.
DR   EMDB; EMD-20678; -.
DR   EMDB; EMD-20682; -.
DR   EMDB; EMD-20686; -.
DR   EMDB; EMD-21705; -.
DR   EMDB; EMD-24109; -.
DR   EMDB; EMD-24110; -.
DR   EMDB; EMD-25650; -.
DR   EMDB; EMD-25651; -.
DR   EMDB; EMD-28209; -.
DR   EMDB; EMD-28210; -.
DR   EMDB; EMD-28211; -.
DR   EMDB; EMD-28212; -.
DR   EMDB; EMD-29046; -.
DR   EMDB; EMD-29047; -.
DR   EMDB; EMD-40582; -.
DR   EMDB; EMD-40583; -.
DR   EMDB; EMD-5688; -.
DR   EMDB; EMD-6580; -.
DR   EMDB; EMD-6618; -.
DR   EMDB; EMD-7118; -.
DR   EMDB; EMD-7119; -.
DR   SMR; Q9WUD2; -.
DR   DIP; DIP-60657N; -.
DR   IntAct; Q9WUD2; 3.
DR   MINT; Q9WUD2; -.
DR   STRING; 10116.ENSRNOP00000004248; -.
DR   BindingDB; Q9WUD2; -.
DR   ChEMBL; CHEMBL2863; -.
DR   DrugCentral; Q9WUD2; -.
DR   GuidetoPHARMACOLOGY; 508; -.
DR   GlyCosmos; Q9WUD2; 2 sites, No reported glycans.
DR   GlyGen; Q9WUD2; 2 sites.
DR   iPTMnet; Q9WUD2; -.
DR   MetOSite; Q9WUD2; -.
DR   PhosphoSitePlus; Q9WUD2; -.
DR   SwissPalm; Q9WUD2; -.
DR   jPOST; Q9WUD2; -.
DR   PaxDb; 10116-ENSRNOP00000004248; -.
DR   GeneID; 29465; -.
DR   KEGG; rno:29465; -.
DR   UCSC; RGD:3965; rat.
DR   AGR; RGD:3965; -.
DR   CTD; 51393; -.
DR   RGD; 3965; Trpv2.
DR   eggNOG; KOG3676; Eukaryota.
DR   InParanoid; Q9WUD2; -.
DR   PhylomeDB; Q9WUD2; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-RNO-3295583; TRP channels.
DR   EvolutionaryTrace; Q9WUD2; -.
DR   PRO; PR:Q9WUD2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0044295; C:axonal growth cone; ISO:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0012505; C:endomembrane system; IDA:UniProtKB.
DR   GO; GO:0032584; C:growth cone membrane; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; IDA:RGD.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005261; F:monoatomic cation channel activity; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISO:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0009266; P:response to temperature stimulus; ISO:RGD.
DR   CDD; cd22197; TRPV2; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008347; TrpV1-4.
DR   NCBIfam; TIGR00870; trp; 1.
DR   PANTHER; PTHR10582:SF5; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 2; 1.
DR   PANTHER; PTHR10582; TRANSIENT RECEPTOR POTENTIAL ION CHANNEL PROTEIN; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Cell membrane; Cytoplasm; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..761
FT                   /note="Transient receptor potential cation channel
FT                   subfamily V member 2"
FT                   /id="PRO_0000215344"
FT   TOPO_DOM        1..392
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        393..413
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        414..433
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        434..454
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        455..460
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        461..481
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        482..495
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        496..516
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        517..537
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        538..558
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        573..609
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        622..642
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        643..761
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          73..115
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00023,
FT                   ECO:0000269|PubMed:16809337"
FT   REPEAT          116..162
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00023,
FT                   ECO:0000269|PubMed:16809337"
FT   REPEAT          163..208
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00023,
FT                   ECO:0000269|PubMed:16809337"
FT   REPEAT          209..244
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00023,
FT                   ECO:0000269|PubMed:16809337"
FT   REPEAT          245..293
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00023,
FT                   ECO:0000269|PubMed:16809337"
FT   REPEAT          294..320
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00023,
FT                   ECO:0000269|PubMed:16809337"
FT   REGION          1..390
FT                   /note="Required for interaction with SLC50A1"
FT                   /evidence="ECO:0000269|PubMed:14991772"
FT   REGION          1..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          56..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          564..587
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          720..761
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        56..70
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        725..744
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTR1"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         748
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTR1"
FT   MOD_RES         760
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        571
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        572
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        151
FT                   /note="L -> P (in Ref. 1 and 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158
FT                   /note="T -> I (in Ref. 4; AAH89215)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        713
FT                   /note="A -> V (in Ref. 4; AAH89215)"
FT                   /evidence="ECO:0000305"
FT   STRAND          38..40
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           77..86
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           89..92
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           95..102
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   STRAND          106..108
FT                   /evidence="ECO:0007829|PDB:8SLX"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   TURN            114..116
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           120..126
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           136..145
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           152..154
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   TURN            160..164
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           167..173
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           177..185
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           197..199
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   STRAND          203..205
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           213..219
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           223..231
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:2ETA"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:6U8A"
FT   HELIX           249..256
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           261..281
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:8EKS"
FT   HELIX           287..289
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           298..304
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           308..321
FT                   /evidence="ECO:0007829|PDB:2ETB"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          328..335
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          338..344
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   TURN            346..348
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          352..354
FT                   /evidence="ECO:0007829|PDB:8EKP"
FT   HELIX           356..362
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           369..372
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           378..388
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           390..412
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           430..465
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   TURN            468..470
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           471..491
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           497..511
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           512..518
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           520..523
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   TURN            530..535
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           537..559
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          560..562
FT                   /evidence="ECO:0007829|PDB:6WKN"
FT   STRAND          590..592
FT                   /evidence="ECO:0007829|PDB:8EKS"
FT   HELIX           593..604
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          614..617
FT                   /evidence="ECO:0007829|PDB:8EKP"
FT   HELIX           619..648
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           656..671
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          676..679
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          686..690
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          693..698
FT                   /evidence="ECO:0007829|PDB:7N0M"
FT   STRAND          701..710
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   HELIX           712..718
FT                   /evidence="ECO:0007829|PDB:8EKQ"
FT   STRAND          723..725
FT                   /evidence="ECO:0007829|PDB:8SLY"
SQ   SEQUENCE   761 AA;  86706 MW;  8977CDE1D5351EC8 CRC64;
     MTSASSPPAF RLETSDGDEE GNAEVNKGKQ EPPPMESPFQ REDRNSSPQI KVNLNFIKRP
     PKNTSAPSQQ EPDRFDRDRL FSVVSRGVPE ELTGLLEYLR WNSKYLTDSA YTEGSTGKTC
     LMKAVLNLQD GVNACIMPLL QIDKDSGNPK LLVNAQCTDE FYQGHSALHI AIEKRSLQCV
     KLLVENGADV HLRACGRFFQ KHQGTCFYFG ELPLSLAACT KQWDVVTYLL ENPHQPASLE
     ATDSLGNTVL HALVMIADNS PENSALVIHM YDGLLQMGAR LCPTVQLEEI SNHQGLTPLK
     LAAKEGKIEI FRHILQREFS GPYQPLSRKF TEWCYGPVRV SLYDLSSVDS WEKNSVLEII
     AFHCKSPNRH RMVVLEPLNK LLQEKWDRLV SRFFFNFACY LVYMFIFTVV AYHQPSLDQP
     AIPSSKATFG ESMLLLGHIL ILLGGIYLLL GQLWYFWRRR LFIWISFMDS YFEILFLLQA
     LLTVLSQVLR FMETEWYLPL LVLSLVLGWL NLLYYTRGFQ HTGIYSVMIQ KVILRDLLRF
     LLVYLVFLFG FAVALVSLSR EARSPKAPED NNSTVTEQPT VGQEEEPAPY RSILDASLEL
     FKFTIGMGEL AFQEQLRFRG VVLLLLLAYV LLTYVLLLNM LIALMSETVN HVADNSWSIW
     KLQKAISVLE MENGYWWCRR KKHREGRLLK VGTRGDGTPD ERWCFRVEEV NWAAWEKTLP
     TLSEDPSGPG ITGNKKNPTS KPGKNSASEE DHLPLQVLQS P
//
